Results 141 to 150 of about 755,616 (163)

Pseudoangiosarcoma and cutaneous collagenous vasculopathy in a patient on a Bruton’s tyrosine kinase inhibitor

open access: yesJAAD Case Reports
Alison H. Kucharik, MD   +5 more
doaj   +1 more source

PROTAC for Bruton’s tyrosine kinase degradation alleviates inflammation in autoimmune diseases

open access: yesCell Discovery
Can Zhu   +11 more
doaj   +1 more source

Novel 5‑Substituted Oxindole Derivatives as Bruton’s Tyrosine Kinase Inhibitors: Design, Synthesis, Docking, Molecular Dynamics Simulation, and Biological Evaluation

open access: yesACS Omega
Vani Madhuri Velavalapalli   +9 more
doaj   +1 more source

Juxtamembrane Autoinhibition in Receptor Tyrosine Kinases

Nature Reviews Molecular Cell Biology, 2004
Stevan R Hubbard
exaly  

Cbl: Many Adaptations to Regulate Protein Tyrosine Kinases

Nature Reviews Molecular Cell Biology, 2001
Christine B F Thien, W Y Langdon
exaly  

Leukocyte Protein Tyrosine Kinases:Potential Targets for Drug Discovery

Annual Review of Immunology, 1997
Joan Brugge, Joseph B Bolen
exaly  

Tyrosine Kinases as Targets for Cancer Therapy

New England Journal of Medicine, 2005
Daniela S Krause   +2 more
exaly  

The Protein Tyrosine Kinase Family of the Human Genome

Oncogene, 2000
Su-Fang Lin, D R Robinson
exaly  

Regulation of Receptor Tyrosine Kinase Signaling by Protein Tyrosine Phosphatases

Trends in Cell Biology, 2001
Arne Östman, Frank-D Böhmer
exaly  

Acquired Mutation of the Tyrosine Kinase JAK2 in Human Myeloproliferative Disorders

Lancet, The, 2005
Wendy Erber   +2 more
exaly  

Home - About - Disclaimer - Privacy